Richard Ducray

The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-2-one)

Kurt G. Pike, Bernard Barlaam, Elaine Cadogan et al. · Journal of Medicinal Chemistry · 2018 · 116 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Two Novel 1,2,4,5-Tetrazines that Participate in Inverse Electron Demand Diels−Alder Reactions with an Unexpected Regioselectivity

Akiyuki Hamasaki, Richard Ducray, Dale L. Boger · The Journal of Organic Chemistry · 2005 · 87 citations · Full text

Natural Sciences, Chemistry, Organic Chemistry +13

Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors

Richard Ducray, Peter Ballard, Bernard Barlaam et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 75 citations · Full text

Medicine, Medicinal Chemistry, Oncology +8

Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase

Sébastien L. Degorce, Bernard Barlaam, Elaine Cadogan et al. · Journal of Medicinal Chemistry · 2016 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Tris(trifluoromethanesulfonyl)methide (“Triflide”) Anion:  Convenient Preparation, X-ray Crystal Structures, and Exceptional Catalytic Activity as a Counterion with Ytterbium(III) and Scandium(III)

Francis J. Waller, Anthony G. M. Barrett, D. Christopher Braddock et al. · The Journal of Organic Chemistry · 1999 · 66 citations

Natural Sciences, Chemistry, Catalysis +12